ASBMT Clinical Research Training Course 2017
The ASBMT Board of Directors created the course in 2006 because of concerns that clinical fellowship programs don’t adequately cover the principles of research and how to take findings from the laboratory to the clinic. The course helps close the gap by addressing those deficiencies. The course includes formal presentations and extensive follow-up dialogue and small-group discussion, covering topics such as:
- Research subject eligibility and recruitment
- Clinical trial design
- Biostatistics
- Data management and quality control
- Study endpoints
- Late effects and quality of life
- Clinical pharmacology, including polypharmacy and drug interactions
- Regulatory compliance
- Relationships with pharmaceutical companies and third-party payers
- Opportunities for grants and clinical research training
- Grant writing
- Working with a mentor
- Translational trials
- Working with laboratory investigators
- Research ethics
- Subject safety
Each participant will be expected to have a research project that can be developed in discussions with faculty and with peers.
This educational activity is being supported by: Incyte, Amgen, Jazz, and Merck
Target Audience
Physicians and allied health professionals
Learning Objectives
At the conclusion of this activity, scholars should be able to:
- Provide Scholars with an opportunity to present their research to their peers and BMT Faculty
- Provide Scholars with critical input regarding clinical trial design and implementation.
- Prepare Scholars for presenting their research at national meetings
- Foster mentoring and networking between faculty and scholars in an intimate environment
- Reinforce participants’ commitment to the stem cell transplantation community
Planning Committee:
Christopher N. Bredeson, MD, MSc
Margaret MacMillan, MD
Corey Cutler, MD - Stanford University Medical Center
Marcos De Lima, MD - University Hospitals - Seidman Cancer Center
Steven Devine, MD - Ohio State University Medical Center
Ronald Gress - NCI/NIH
Joycelynn Palmer, PhD - (Course Statistician) City of Hope national Medical Center
Ted Gooley, PhD - (Course Statistician) Fred hutchinson Cancer Research Center
Partow Kebriaei, MD - MD Anderson Cancer Center
Carlos Almeida Ramos, MD - Baylor College of Medicine
All persons in control of content have NO relevant financial relationships to disclose with the exception of the following and in accordance with the ACCME® standards for Commercial Support Number 6, these relationships were reviewed via the MCW conflict of interest resolution process and resolved.
Name | Company | Role |
Christopher Bredeson, MD, MSc, FRCPC | Celenge | Chairperson |
Jazz | Advisory Board | |
Kite Pharma | DSMB | |
Corey Cutler, MD, MPH | Pfizer, Pharmacyclics | Consultant |
Kite, BMS | Consultant | |
Steven Devine | Incyte, Kiadis | Advisor |
Joycelynne Palmer, PhD | Gilead Sciences | DSMB |
Ted Gooley, PhD | Nohla Therapeutics | Consultant |
Agensys | IDMC Member | |
Pharmacyclics | DMC Member | |
Carlos Almeider Ramos, MD | Tessa Therapeutics | Principal Investigator |
Margaret MacMillan, MD, MSc, FRCPC | Magenta Therapeutics | Consultant |
Available Credit
- 36.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 36.00 Hours of ParticipationHours of Participation credit.